Alexion Pharma – (NASDAQ:ALXN)

Finance December 11, 2015

Breaking: Stifel Reconfirms $245.0 Price Objective On Alexion Pharma (NASDAQ:ALXN) Shares, Reconfirms Their Original “Buy” Rating

Alexion Pharma (NASDAQ:ALXN) Rating Reaffirmed Alexion Pharma (NASDAQ:ALXN) just had their share rating of a ‘”Buy”‘ issued by research analysts at Stifel, who now has…

Finance December 11, 2015

TOday’s Movers: Alexion Pharma (NASDAQ:ALXN) Stock Rating Reiterated by Analysts at Stifel; $245 Target Price Indicates 30.58% Potential

Alexion Pharma (NASDAQ:ALXN) Rating Reaffirmed Stifel now has a $245 TP on the $41.27B market cap company or 30.58% upside potential. In recent note sent…